Methylphenidate-Induced Enuresis: 3 Case Reports

Uzun N., Akinci M. A., Karatoprak S.

CLINICAL NEUROPHARMACOLOGY, cilt.44, sa.1, ss.37-38, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 44 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1097/wnf.0000000000000422
  • Dergi Adı: CLINICAL NEUROPHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE, MLA - Modern Language Association Database, Psycinfo
  • Sayfa Sayıları: ss.37-38
  • Anahtar Kelimeler: methylphenidate, ADHD, enuresis, children, side effect, ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, CHILDREN
  • Atatürk Üniversitesi Adresli: Evet

Özet

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children and adolescents. Methylphenidate (MPH) is one of the most widely used drugs in the treatment of ADHD. Enuresis can occur comorbidly with ADHD. However, enuresis is sometimes seen in patients with ADHD as an adverse effect of MPH treatment. In contrast, in some cases, MPH reportedly improves enuresis in patients with ADHD comorbid with enuresis. The literature is contradictory with regard to the relationship between MPH and enuresis. This report presents the cases of 3 children with ADHD who displayed enuresis during MPH treatment.